Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome

    loading  Checking for direct PDF access through Ovid

Abstract

Cardiovascular disease remains the leading cause of death in men and women in the United States. Aggressive treatment of insulin resistance and its associated lipid abnormalities remains a top priority for preventing cardiovascular morbidity and mortality.

Related Topics

    loading  Loading Related Articles